Insider Transactions by ODINK DEBRA

Symbol	Relationship	Date	Transaction	Cost	# Shares	Value($)	Total Shares	Form 4
ANTH	Chief Technology Officer	Oct 12, 2015	Sale	$6.15	1,205	7,411	7,896	Oct 13, 2015, 08:02 PM
ANTH	Chief Technology Officer	Mar 25, 2014	Option Exercise	$3.30	2,783	9,184	6,601	Mar 27, 2014, 09:57 PM
ANTH	Chief Technology Officer	Jun 30, 2013	Option Exercise	$0.49	2,248	1,102	75,074	Jul 02, 2013, 09:17 PM
ANTH	Chief Technology Officer	Jan 03, 2013	Option Exercise	$0.69	3,409	2,352	31,812	Jan 07, 2013, 09:18 PM
ANTH	Chief Technology Officer	Jun 30, 2012	Option Exercise	$0.69	1,838	1,268	24,821	Jul 03, 2012, 07:27 PM
ANTH	Chief Technology Officer	Mar 01, 2012	Sale	$6.57	2,000	13,140	26,659	Mar 05, 2012, 04:01 PM
ANTH	Chief Technology Officer	Feb 01, 2012	Sale	$7.67	2,000	15,340	21,241	Feb 03, 2012, 04:01 PM
ANTH	Chief Technology Officer	Jan 10, 2012	Sale	$6.51	800	5,205	23,241	Jan 12, 2012, 12:58 PM
ANTH	Chief Technology Officer	Jan 06, 2012	Sale	$6.50	1,200	7,800	24,441	Jan 10, 2012, 02:27 PM
ANTH	VP, Pharmaceutical R&D	Jun 30, 2011	Option Exercise	$8.17	3,670	29,984	25,641	Jul 05, 2011, 06:23 PM
ANTH	VP, Pharmaceutical R&D	Apr 13, 2011	Option Exercise	$1.51	3,311	5,000	29,311	Apr 14, 2011, 08:36 PM
ANTH	VP, Pharmaceutical R&D	Sep 24, 2010	Buy	$4.20	1,000	4,200	26,000	Sep 24, 2010, 09:22 PM

Desktop Version

Symbol	Relationship	Date	Transaction	Value($)
ANTH	Chief Technology Officer	Oct 12, 2015	Sale	7,411
ANTH	Chief Technology Officer	Mar 25, 2014	Option Exercise	9,184
ANTH	Chief Technology Officer	Jun 30, 2013	Option Exercise	1,102
ANTH	Chief Technology Officer	Jan 03, 2013	Option Exercise	2,352
ANTH	Chief Technology Officer	Jun 30, 2012	Option Exercise	1,268
ANTH	Chief Technology Officer	Mar 01, 2012	Sale	13,140
ANTH	Chief Technology Officer	Feb 01, 2012	Sale	15,340
ANTH	Chief Technology Officer	Jan 10, 2012	Sale	5,205
ANTH	Chief Technology Officer	Jan 06, 2012	Sale	7,800
ANTH	VP, Pharmaceutical R&D	Jun 30, 2011	Option Exercise	29,984
ANTH	VP, Pharmaceutical R&D	Apr 13, 2011	Option Exercise	5,000
ANTH	VP, Pharmaceutical R&D	Sep 24, 2010	Buy	4,200